Orbit Biomedical Limited is a Stevenage-based company founded in 2016 by Michael Keane.
Orbit Biomedical Limited is a clinical-stage retinal gene therapygene therapy company developing gene therapy beyond rare disease to treat a leading cause of blindness, dry age-related macular degeneration (AMD).
Orbit Biomedical Limited is a clinical-stage retinal gene therapy company developing gene therapy beyond rare disease to treat a leading cause of blindness, dry age-related macular degeneration (AMD).